Rethinking ‘Innovation’ in Psychiatry with Older and Newer Treatments: From Bench to Benchside-Reference-Cited by-同舟云学术

Rethinking ‘Innovation’ in Psychiatry with Older and Newer Treatments: From Bench to Benchside

Published:2023-11 Issue:11 Volume:21 Page:2176-2177
ISSN:1570-159X
Container-title:Current Neuropharmacology
language:en
Short-container-title:CN

Author:

De Berardis Domenico¹²³⁴,Martinotti Giovanni⁵⁶

Affiliation:

1. Department of Mental Health, ASL 4 Teramo, Italy

2. Nursing School, University of L'Aquila, Italy

3. Department of Neuroscience, Imaging, Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, Chieti, Italy

4. International Centre for Education and Research in Neuropsychiatry (ICERN), Samara State Medical University, Samara, Russia

5. Department of Clinical and Pharmaceutical Sciences, University of Hertfordshire, Hatfield, UK

6. National Health Service, Department of Mental Health, Contrada Casalena, 64100 Teramo, Italy

Abstract

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology,General Medicine

Reference7 articles.

1. Fiorillo A.; Ventriglio A.; Sampogna G.; Falkai P.; Innovations in psychiatry: Challenges and future directions. Int Rev Psychiatry 2022,34(7-8),659-662

2. Kalin N.H.; Scientific advances supporting new and improved treatment strategies in psychiatry. Am J Psychiatry 2021,178(5),365-368

3. Mosca A.; Chiappini S.; Miuli A.; Mancusi G.; Santovito M.C.; Carlo F.D.; Pettorruso M.; Corkery J.M.; Canessa C.; Martinotti G.; Giannantonio M.D.; Ibogaine/Noribogaine in the treatment of substance use disorders: A systematic review of the current literature. Curr Neuropharmacol 2022,21,2178-2194

4. Corkery J.M.; Martinotti G.; Schifano F.; Contribution of drugs to drownings in Scotland, 1996-2020. Curr Neuropharmacol 2022,2022,2217-2226

5. Dell’Osso B.B.A.; Conca A.P.M.; Salvi V.; Siracusano A.; Zaffora C.; De Berardis D.; Di Giannantonio M.; Therapeutic appropriateness of Cariprazine in the management of Schizophrenia: Experts’ Opinion using a Delphi Approach. Curr Neuropharmacol 2021,22(4),415-426